Study of (p,x) reactions in the natCaO targets

The development of novel medical radioisotopes for diagnostic and therapeutic purposes is critical for the advancement of personalized nuclear medicine. Radio metals contain promising theranostic pairs and can be used to label proteins and peptides. Scandium radionuclides have recently gained a lot of attention for their radiation characteristics (such as half-life, β particle and gamma emission energies) in order to improve the efficiency of medical care or therapeutic benefit for specific groups of patients.